• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Transamerica Corporation

Transamerica Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA -8995 in Dyslipidemia

    Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA -8995 in Dyslipidemia

  2. American Capital Leads Second Lien Financing to Support the Acquisition of Tectum Holdings, Inc.

    American Capital Leads Second Lien Financing to Support the Acquisition of Tectum Holdings, Inc.

  3. Oil Refineries Announces Results For Second Quarter And First Half 2014

    Oil Refineries Announces Results For Second Quarter And First Half 2014

  4. Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

    Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

  5. The Best-Laid Succession Plans

    When a firm's culture and investment strategy hinge on its founder, what happens when that founder is no longer around?

  6. The Best-Laid Succession Plans

    When a firm's culture and investment strategy hinge on its founder, what happens when that founder is no longer around?

  7. The Error-Proof Portfolio: How Do Your Financial Priorities Stack Up With Our Pyramid?

    Make sure you're not geeking out about small-bore investment problems while giving short shrift to the game-changers.

  8. Columbia Merges Away More Poor Funds

    Bart Geer takes over BlackRock Basic Value, Marsico Capital restructures its debt, and more.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.